Fernandez-Penas P - Search Results

1

Real-world data on the efficacy and safety of hedgehog pathway inhibitors in patients with basal cell carcinoma: Experience of a tertiary Australian centre.

Truong K, Peera M, Liu R, Wijaya M, Jones-Caballero M, Araujo RR, Fernandez-Penas P. Truong K, et al. Among authors: fernandez penas p. Australas J Dermatol. 2024 Dec;65(8):e248-e254. doi: 10.1111/ajd.14373. Epub 2024 Oct 25. Australas J Dermatol. 2024. PMID: 39451045

2

A Polypodium leucotomos extract inhibits solar-simulated radiation-induced TNF-alpha and iNOS expression, transcriptional activation and apoptosis.

Jańczyk A, Garcia-Lopez MA, Fernandez-Peñas P, Alonso-Lebrero JL, Benedicto I, López-Cabrera M, Gonzalez S. Jańczyk A, et al. Exp Dermatol. 2007 Oct;16(10):823-9. doi: 10.1111/j.1600-0625.2007.00603.x. Exp Dermatol. 2007. PMID: 17845214

3

Cutaneous epithelioid angiosarcoma occurring at a peristomal site.

Fessa CK, Sharma R, Fernández-Peñas P. Fessa CK, et al. J Am Acad Dermatol. 2010 Aug;63(2):e55-6. doi: 10.1016/j.jaad.2009.11.026. J Am Acad Dermatol. 2010. PMID: 20633792 No abstract available.

4

Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors).

Liu R, Fernandez-Peñas P, Sebaratnam DF. Liu R, et al. Med J Aust. 2017 May 15;206(9):412. doi: 10.5694/mja16.01357. Med J Aust. 2017. PMID: 28490308 No abstract available.

5

Atypical fibroxanthoma management: Recurrence, metastasis and disease-specific death.

Polcz MM, Sebaratnam DF, Fernández-Peñas P. Polcz MM, et al. Australas J Dermatol. 2018 Feb;59(1):10-25. doi: 10.1111/ajd.12646. Epub 2017 Aug 17. Australas J Dermatol. 2018. PMID: 28815551 Review.

6

Naevus lightening in melanoma patients under BRAF/MEK inhibitor combination therapy versus checkpoint immunotherapy: A histological and immunohistochemistry analysis.

Zhao CY, Chou S, Liu RC, Fernandez-Peñas P. Zhao CY, et al. Pigment Cell Melanoma Res. 2018 Mar;31(2):341-344. doi: 10.1111/pcmr.12669. Epub 2017 Nov 27. Pigment Cell Melanoma Res. 2018. PMID: 29131505 No abstract available.

7

Management of the cutaneous adverse effects of antimelanoma therapy.

Liu RC, Consuegra G, Fernández-Peñas P. Liu RC, et al. Melanoma Manag. 2017 Dec;4(4):187-202. doi: 10.2217/mmt-2017-0015. Epub 2017 Nov 22. Melanoma Manag. 2017. PMID: 30190925 Free PMC article. Review.

8

Vitiligo-like depigmentation in oncology patients treated with immunotherapies for nonmelanoma metastatic cancers.

Liu RC, Consuegra G, Chou S, Fernandez Peñas P. Liu RC, et al. Clin Exp Dermatol. 2019 Aug;44(6):643-646. doi: 10.1111/ced.13867. Epub 2019 Jan 7. Clin Exp Dermatol. 2019. PMID: 30618056

9

Keratinocyte carcinoma as a chronic disease in Australia and Spain: The importance of avoidance of perceived visible scars.

Venning VL, Thomas CL, Consuegra Romero G, Castro Gutiérrez B, St George G, Fernandez-Peñas P. Venning VL, et al. Australas J Dermatol. 2019 Nov;60(4):284-287. doi: 10.1111/ajd.13050. Epub 2019 Apr 10. Australas J Dermatol. 2019. PMID: 30968391

10

Increased collaboration between Mohs and plastic surgeons in the surgical management of skin cancer in Australia.

Venning VL, Moreno-Bonilla G, Stewart TJ, Lee S, Fernandez-Peñas P. Venning VL, et al. Australas J Dermatol. 2020 Feb;61(1):85-87. doi: 10.1111/ajd.13112. Epub 2019 Jul 10. Australas J Dermatol. 2020. PMID: 31292946 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters